124i-psca
mAbexperimentalImaging agent
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 22, 2013 (NCT02092948)
Timeline
No events for the selected filters.
Mechanism of action
- Prostate stem cell antigenRadiopharmaceutical
PSCA radiopharmaceutical
Chemistry & pharmacology
- Multi-specific
- No
- Imaging
- 124-iodine
Oral
No
Parenteral
No
Topical
No
Also known as
- 124i-psca
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02092948 | N/A | Aug 22, 2013 | ImaginAb, Inc., University of California, Los Angeles |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ImaginAb, Inc. | For profit | 1 | 0 | 1 | 2013 |
| University of California, Los Angeles | Academic/Hospital | 1 | 1 | 1 | 2013 |
2 organizations
Page 1 / 1